Literature DB >> 34747495

Prevention of Late Recurrence: An Increasingly Important Target for Breast Cancer Research and Control.

Serban Negoita1, Esmeralda Ramirez-Pena1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34747495      PMCID: PMC8902437          DOI: 10.1093/jnci/djab203

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  18 in total

1.  From normal response to clinical problem: definition and clinical features of fear of cancer recurrence.

Authors:  Sophie Lebel; Gozde Ozakinci; Gerald Humphris; Brittany Mutsaers; Belinda Thewes; Judith Prins; Andreas Dinkel; Phyllis Butow
Journal:  Support Care Cancer       Date:  2016-05-12       Impact factor: 3.603

Review 2.  Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Authors:  S Gourgou-Bourgade; D Cameron; P Poortmans; B Asselain; D Azria; F Cardoso; R A'Hern; J Bliss; J Bogaerts; H Bonnefoi; E Brain; M J Cardoso; B Chibaudel; R Coleman; T Cufer; L Dal Lago; F Dalenc; E De Azambuja; M Debled; S Delaloge; T Filleron; J Gligorov; M Gutowski; W Jacot; C Kirkove; G MacGrogan; S Michiels; I Negreiros; B V Offersen; F Penault Llorca; G Pruneri; H Roche; N S Russell; F Schmitt; V Servent; B Thürlimann; M Untch; J A van der Hage; G van Tienhoven; H Wildiers; J Yarnold; F Bonnetain; S Mathoulin-Pélissier; C Bellera; T S Dabakuyo-Yonli
Journal:  Ann Oncol       Date:  2015-02-27       Impact factor: 32.976

3.  A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data.

Authors:  Hava Izci; Tim Tambuyzer; Krizia Tuand; Victoria Depoorter; Annouschka Laenen; Hans Wildiers; Ignace Vergote; Liesbet Van Eycken; Harlinde De Schutter; Freija Verdoodt; Patrick Neven
Journal:  J Natl Cancer Inst       Date:  2020-10-01       Impact factor: 13.506

4.  Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States.

Authors:  Angela B Mariotto; Ruth Etzioni; Marc Hurlbert; Lynne Penberthy; Musa Mayer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-05-18       Impact factor: 4.254

Review 5.  Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis.

Authors:  Cameron B Haas; Larissa Nekhlyudov; Janie M Lee; Sara H Javid; Mary Bush; Dianne Johnson; Timothy Gleason; Cary Kaufman; Jennifer Specht; Sean Stitham; Karen J Wernli
Journal:  Breast Cancer Res Treat       Date:  2020-04-17       Impact factor: 4.872

6.  Validation of an Algorithm to Ascertain Late Breast Cancer Recurrence Using Danish Medical Registries.

Authors:  Rikke Nørgaard Pedersen; Buket Öztürk; Lene Mellemkjær; Søren Friis; Trine Tramm; Mette Nørgaard; Deirdre P Cronin-Fenton
Journal:  Clin Epidemiol       Date:  2020-10-14       Impact factor: 4.790

7.  Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States.

Authors:  Shirley M Bluethmann; Angela B Mariotto; Julia H Rowland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-07       Impact factor: 4.254

8.  Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer.

Authors:  Pattaraporn Wangchinda; Suthinee Ithimakin
Journal:  World J Surg Oncol       Date:  2016-08-24       Impact factor: 2.754

9.  The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis.

Authors:  Rikke Nørgaard Pedersen; Buket Öztürk Esen; Lene Mellemkjær; Peer Christiansen; Bent Ejlertsen; Timothy Lee Lash; Mette Nørgaard; Deirdre Cronin-Fenton
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 13.506

10.  Recurrence rates and long-term survival factors in young women with breast cancer.

Authors:  Hassan K Abdulwassi; Ibrahim T Amer; Ahmad H Alhibshi; Abdullah A Alnajjar; Abdulrahman K Bahatheq; Nora H Trabulsi; Mohammed O Nassif
Journal:  Saudi Med J       Date:  2020-04       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.